1. Home
  2. CYTK vs SEE Comparison

CYTK vs SEE Comparison

Compare CYTK & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • SEE
  • Stock Information
  • Founded
  • CYTK 1997
  • SEE 1960
  • Country
  • CYTK United States
  • SEE United States
  • Employees
  • CYTK N/A
  • SEE N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • SEE Major Chemicals
  • Sector
  • CYTK Health Care
  • SEE Industrials
  • Exchange
  • CYTK Nasdaq
  • SEE Nasdaq
  • Market Cap
  • CYTK 4.6B
  • SEE 4.6B
  • IPO Year
  • CYTK 2004
  • SEE N/A
  • Fundamental
  • Price
  • CYTK $49.76
  • SEE $33.86
  • Analyst Decision
  • CYTK Buy
  • SEE Strong Buy
  • Analyst Count
  • CYTK 15
  • SEE 10
  • Target Price
  • CYTK $75.57
  • SEE $38.80
  • AVG Volume (30 Days)
  • CYTK 2.7M
  • SEE 1.3M
  • Earning Date
  • CYTK 11-05-2025
  • SEE 11-06-2025
  • Dividend Yield
  • CYTK N/A
  • SEE 2.37%
  • EPS Growth
  • CYTK N/A
  • SEE N/A
  • EPS
  • CYTK N/A
  • SEE 1.98
  • Revenue
  • CYTK $85,738,000.00
  • SEE $5,325,400,000.00
  • Revenue This Year
  • CYTK $330.96
  • SEE N/A
  • Revenue Next Year
  • CYTK $73.41
  • SEE $1.94
  • P/E Ratio
  • CYTK N/A
  • SEE $17.06
  • Revenue Growth
  • CYTK 2635.74
  • SEE N/A
  • 52 Week Low
  • CYTK $29.31
  • SEE $22.78
  • 52 Week High
  • CYTK $59.39
  • SEE $38.85
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 63.01
  • SEE 65.08
  • Support Level
  • CYTK $49.22
  • SEE $32.66
  • Resistance Level
  • CYTK $53.58
  • SEE $34.21
  • Average True Range (ATR)
  • CYTK 2.54
  • SEE 0.72
  • MACD
  • CYTK 0.29
  • SEE 0.12
  • Stochastic Oscillator
  • CYTK 76.53
  • SEE 85.83

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SEE Sealed Air Corporation

Sealed Air is organized via two reporting segments. Food includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Protective includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.

Share on Social Networks: